← Back to guidelines
Cardiology34 papers

Tachycardia-induced cardiomyopathy

Last edited: 4/22/2026

Overview

Tachycardia-induced cardiomyopathy (TIC) results from sustained rapid heart rates leading to myocardial dysfunction, often observed in conditions like atrial fibrillation, atrial flutter, and incessant ventricular tachycardias 1234.

Diagnosis

  • Clinical Presentation: History of sustained tachyarrhythmias with signs of heart failure 234.
  • Echocardiography: Demonstrates left ventricular dysfunction, often with reduced ejection fraction 234.
  • Electrophysiological Studies: May reveal conduction abnormalities like prolonged HV interval or 2:1 AV block 3.
  • Genetic Testing: Consider in cases with suspected heritable arrhythmia syndromes (e.g., KCNQ1 mutations) 1.
  • Management

  • Rhythm Control: Achieving and maintaining sinus rhythm through antiarrhythmic drugs or catheter ablation 234.
  • Catheter Ablation: Effective for refractory cases of AVNRT and junctional reciprocating tachycardia 34.
  • Supportive Care: Includes heart failure management with diuretics, ACE inhibitors, and beta-blockers as appropriate 2.
  • Special Populations

  • Pediatrics: Catheter ablation can be effective in treating tachycardia-induced cardiomyopathy in children with permanent junctional reciprocating tachycardia 4.
  • Comorbidities: Management should consider underlying arrhythmias refractory to pharmacotherapy, emphasizing the role of catheter ablation 34.
  • Key Recommendations

  • Achieve and Maintain Sinus Rhythm: For patients with tachycardia-induced cardiomyopathy, rhythm control strategies significantly improve left ventricular function and reduce heart failure hospitalizations (Evidence: Moderate 2).
  • Consider Catheter Ablation for Refractory Cases: Radiofrequency catheter ablation is an effective treatment, particularly in cases unresponsive to pharmacological therapy (Evidence: Weak 34).
  • Monitor and Manage Heart Failure Symptoms: Implement standard heart failure management protocols alongside rhythm control to support myocardial function (Evidence: Moderate 2).
  • References

    1 Anders M, Hoppe S, Eberl H, Rebs S, Seedorf A, Maurer W et al.. Generation of pluripotent stem cell line (IPWi001-A) and a corresponding CRISPR/Cas9 modified isogenic rescue control (IPWi001-A-1) from a patient with arrhythmia-induced cardiomyopathy harboring a KCNQ1 truncating mutation. Stem cell research 2026. link 2 Ahmad A, Mar PL, Olshansky B, Horbal P, Tsai C, Patel H et al.. Echocardiographic changes and heart failure hospitalizations following rhythm control for arrhythmia-induced cardiomyopathy: results from a multicenter, retrospective study. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2023. link 3 Furushima H, Chinushi M, Sugiura H, Aizawa Y. Radiofrequency catheter ablation for incessant atrioventricular nodal reentrant tachycardia normalized H-V block associated with tachycardia-induced cardiomyopathy. Journal of electrocardiology 2004. link 4 Semizel E, Ayabakan C, Ceviz N, Celiker A. Permanent form of junctional reciprocating tachycardia and tachycardia-induced cardiomyopathy treated by catheter ablation: a case report. The Turkish journal of pediatrics 2003. link 5 Mall G, Mattfeldt T, Rieger P, Volk B, Frolov VA. Morphometric analysis of the rabbit myocardium after chronic ethanol feeding - early capillary changes. Basic research in cardiology 1982. link

    Original source

    1. [1]
    2. [2]
      Echocardiographic changes and heart failure hospitalizations following rhythm control for arrhythmia-induced cardiomyopathy: results from a multicenter, retrospective study.Ahmad A, Mar PL, Olshansky B, Horbal P, Tsai C, Patel H et al. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2023)
    3. [3]
    4. [4]
    5. [5]
      Morphometric analysis of the rabbit myocardium after chronic ethanol feeding - early capillary changes.Mall G, Mattfeldt T, Rieger P, Volk B, Frolov VA Basic research in cardiology (1982)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG